There has been a change to the Prescribing Information. Click here to see changes.
>Healthcare Provider Patient Counseling Guide
Review useful tips to help you have a balanced counseling session with your patients about ORILISSA.
ORILISSA® (elagolix) is indicated for the management of moderate to severe pain associated with endometriosis.
These are not all the possible side effects of ORILISSA.
Safety and effectiveness of ORILISSA in patients less than 18 years of age have not been established.
US-ORIL-200330
For more information, please click here for full Prescribing Information.
1. ORILISSA [package insert]. North Chicago, IL: AbbVie Inc.